Genmab A (GMAB) Operating Leases: 2019-2023
- Genmab A's Operating Leases rose 21.42% to $68.57 in Q2 2023 from the same period last year, while for Jun 2023 it was $68.57, marking a year-over-year increase of 21.42%. This contributed to the annual value of $1.4 million for FY2020, which is 41.72% down from last year.
- As of Q2 2023, Genmab A's Operating Leases stood at $68.57, which was down 87.53% from $550 recorded in Q3 2022.
- Over the past 5 years, Genmab A's Operating Leases peaked at $17.2 million during Q2 2019, and registered a low of $32.32 during Q2 2020.
- In the last 3 years, Genmab A's Operating Leases had a median value of $62.53 in 2022 and averaged $180.16.
- Per our database at Business Quant, Genmab A's Operating Leases slumped by 100.00% in 2020 and then surged by 41.09% in 2021.
- Genmab A's Operating Leases (Quarterly) stood at $2.4 million in 2019, then slumped by 41.72% to $1.4 million in 2020, then soared by 41.09% to $45.60 in 2021, then increased by 23.86% to $550 in 2022, then grew by 21.42% to $68.57 in 2023.
- Its last three reported values are $68.57 in Q2 2023, $550 for Q3 2022, and $56.48 during Q2 2022.
